Ahuja H, Sharma BC, Sachdeva S et al (2023) A double blind randomized controlled trial to assess efficacy of nutritional therapy for prevention of recurrence of hepatic encephalopathy in patients with cirrhosis. J Gastroenterol Hepatol 38:433–440. https://doi.org/10.1111/jgh.16096

Article  CAS  PubMed  Google Scholar 

An J, Kim KW, Han S et al (2014) Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment Pharmacol Ther 39:1418–1426. https://doi.org/10.1111/apt.12771

Article  CAS  PubMed  Google Scholar 

Bischoff SC, Bernal W, Dasarathy S et al (2020) ESPEN Guideline ESPEN practical guideline: Clinical nutrition in liver disease. https://doi.org/10.1016/j.clnu.2020.09.001

Butterworth RF (1996) The neurobiology of hepatic encephalopathy. Semin Liver Dis 16:235–244. https://doi.org/10.1055/s-2007-1007236

Article  CAS  PubMed  Google Scholar 

Butterworth RF (2003) Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies. J Hepatol 39:278–285. https://doi.org/10.1016/s0168-8278(03)00267-8

Article  PubMed  Google Scholar 

Chavarria L, Cordoba J (2015) Magnetic Resonance Imaging and spectroscopy in hepatic Encephalopathy. J Clin Exp Hepatol 5:69–74. https://doi.org/10.1016/j.jceh.2013.10.001

Article  Google Scholar 

Cichoz-Lach H, Michalak A (2013) Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol 19:26–34. https://doi.org/10.3748/WJG.V19.I1.26

Article  PubMed  PubMed Central  Google Scholar 

D’Antiga L, Dacchille P, Boniver C et al (2014a) Clues for minimal hepatic encephalopathy in children with noncirrhotic portal hypertension. J Pediatr Gastroenterol Nutr 59:689–694. https://doi.org/10.1097/MPG.0000000000000537

Article  PubMed  Google Scholar 

D’Antiga L, Dacchille P, Boniver C et al (2014b) Clues for minimal hepatic encephalopathy in children with noncirrhotic portal hypertension. J Pediatr Gastroenterol Nutr 59:689–694. https://doi.org/10.1097/MPG.0000000000000537

Article  PubMed  Google Scholar 

De Campos Franzoni L, De Carvalho FC, De Almeida Garzon RG et al (2014) Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy. World J Gastroenterol 20:15910. https://doi.org/10.3748/WJG.V20.I42.15910

Article  Google Scholar 

De Gottardi A, Sempoux C, Berzigotti A (2022) Porto-sinusoidal vascular disorder. J Hepatol 77:1124–1135. https://doi.org/10.1016/J.JHEP.2022.05.033/ATTACHMENT/38A58AD7-CFB6-41BD-853D-31DA0E003DDE/MMC1.PDF

Article  PubMed  Google Scholar 

El-Karaksy HM, Afifi O, Bakry A et al (2017) A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction. World J Pediatr 13:70–75. https://doi.org/10.1007/S12519-016-0066-2

Article  CAS  PubMed  Google Scholar 

Fu J, Gao Y, Shi L (2022) Combination therapy with rifaximin and lactulose in hepatic encephalopathy: a systematic review and meta-analysis. PLoS ONE 17. https://doi.org/10.1371/JOURNAL.PONE.0267647

Gioia S, Nardelli S, Riggio O et al (2021) Cognitive impairement in non-cirrhotic portal hypertension: highlights on Physiopathology, diagnosis and management. J Clin Med 11. https://doi.org/10.3390/jcm11010101

Giri S, Singh A, Angadi S et al (2023) Prevalence of hepatic encephalopathy in patients with non-cirrhotic portal hypertension: a systematic review and meta-analysis. Indian J Gastroenterol 42:642–650. https://doi.org/10.1007/s12664-023-01412-1

Article  PubMed  Google Scholar 

Gluud LL, Dam G, Les I et al (2017) Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev 2017. https://doi.org/10.1002/14651858.CD001939.PUB4

Goel A, Yadav S, Saraswat V et al (2010) Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction. Liver Int 30:1143–1151. https://doi.org/10.1111/j.1478-3231.2010.02289.x

Article  CAS  PubMed  Google Scholar 

Gwon D, Il, Kim YH, Ko GY et al (2015) Vascular Plug-assisted Retrograde Transvenous Obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective Multicenter Study. J Vasc Interv Radiol 26:1589–1595. https://doi.org/10.1016/J.JVIR.2015.07.011

Article  PubMed  Google Scholar 

Jain L, Sharma BC, Srivastava S et al (2013) Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol 28:1187–1193. https://doi.org/10.1111/JGH.12160

Article  CAS  PubMed  Google Scholar 

Khanna R, Sarin SK (2014) Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol 60:421–441. https://doi.org/10.1016/J.JHEP.2013.08.013

Article  PubMed  Google Scholar 

Laleman W, Simon-Talero M, Maleux G et al (2013) Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology 57:2448–2457. https://doi.org/10.1002/hep.26314

Article  PubMed  Google Scholar 

Lautz TB, Tantemsapya N, Rowell E, Superina RA (2011) Management and classification of type II congenital portosystemic shunts. J Pediatr Surg 46:308–314. https://doi.org/10.1016/j.jpedsurg.2010.11.009

Article  PubMed  Google Scholar 

Lee EW, Lee AE, Saab S, Kee ST (2020) Retrograde Transvenous Obliteration (RTO): a New Treatment option for hepatic Encephalopathy. Dig Dis Sci 65:2483–2491. https://doi.org/10.1007/S10620-020-06050-7

Article  CAS  PubMed  Google Scholar 

Lee H, Yoo J-J, Ahn SH, Kim BK (2022) New evidence of oral branched-chain amino acid supplementation on the prognosis of patients with Advanced Liver Disease. Clin Transl Gastroenterol 13:e00542. https://doi.org/10.14309/ctg.0000000000000542

Article  PubMed  PubMed Central  Google Scholar 

Liu M, He WT, Chen DS, Hu DH (2019a) [Analysis of influencing factors on hepatic encephalopathy in patients with non-cirrhotic portal hypertension]. Zhonghua Gan Zang Bing Za Zhi 27:673–676. https://doi.org/10.3760/CMA.J.ISSN.1007-3418.2019.09.003

Article  CAS  PubMed  Google Scholar 

Liu M, He WT, Chen DS, Hu DH (2019b) [Analysis of influencing factors on hepatic encephalopathy in patients with non-cirrhotic portal hypertension]. Zhonghua Gan Zang Bing Za Zhi 27:673–676. https://doi.org/10.3760/cma.j.issn.1007-3418.2019.09.003

Article  CAS  PubMed  Google Scholar 

Lv Y, Li K, He C et al (2019) TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis. Aliment Pharmacol Ther 49:926–939. https://doi.org/10.1111/apt.15186

Article  PubMed  Google Scholar 

Maharshi S, Sharma BC, Sachdeva S et al (2016) Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a Randomized Trial. Clin Gastroenterol Hepatol 14:454–460e3. https://doi.org/10.1016/J.CGH.2015.09.028

Article  PubMed  Google Scholar 

Masson S, Mardini HA, Rose JD, Record CO (2008) Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM: Int J Med 101:493–501. https://doi.org/10.1093/QJMED/HCN037

Article  CAS  Google Scholar 

Matthews TJ, Trochsler MI, Bridgewater FH, Maddern GJ (2014) Systematic review of congenital and acquired portal-systemic shunts in otherwise normal livers. Br J Surg 101:1509–1517. https://doi.org/10.1002/bjs.9619

Article  CAS  PubMed  Google Scholar 

Metcalfe EL, Avenell A, Fraser A (2014) Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review. Clin Nutr 33:958–965. https://doi.org/10.1016/J.CLNU.2014.02.011

Article  CAS  PubMed  Google Scholar 

Misra AGRCSSK (1997) Monoethylene glycine xylidide (MEGX). A sensitive non-invasive method to differentiate NCPF and Child’s a chronic liver disease. Ind J Gastroenterol 16:A–101

Google Scholar 

Nicoletti V, Gioia S, Lucatelli P et al (2016a) Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: description, prevalence and risk factors. Dig Liver Dis 48:1072–1077. https://doi.org/10.1016/j.dld.2016.06.014

Article  PubMed  Google Scholar 

Nicoletti V, Gioia S, Lucatelli P et al (2016b) Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: description, prevalence and risk factors. Dig Liver Disease 48:1072–1077. https://doi.org/10.1016/J.DLD.2016.06.014